XML 100 R84.htm IDEA: XBRL DOCUMENT v3.6.0.2
Sale of Algenist and Discontinued Operations Income Statement Reclassifications (Details) - USD ($)
3 Months Ended 5 Months Ended 12 Months Ended
Dec. 31, 2016
Sep. 30, 2016
Jun. 30, 2016
Mar. 31, 2016
Dec. 31, 2015
Sep. 30, 2015
Jun. 30, 2015
Mar. 31, 2015
Dec. 31, 2016
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                        
Income tax provision $ (223,000) $ (1,839,000) $ 0 $ 0 $ 0 $ 0 $ 0 $ 0   $ (2,062,000) $ 0 $ 0
Income (loss) from discontinued operations $ 71,000 $ 5,852,000 $ (1,577,000) $ (1,045,000) $ (1,644,000) $ 268,000 $ (736,000) $ (953,000)   3,301,000 (3,065,000) (980,000)
Algenist skincare | Discontinued Operations, Disposed of by Sale                        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                        
Total revenues                 $ 8,843,000 13,674,000 23,278,000 24,429,000
Cost of product revenues                   4,724,000 7,616,000 7,746,000
Sales, general and administrative                   12,525,000 18,692,000 17,645,000
Total costs and operating expenses                   17,249,000 26,308,000 25,391,000
Income (loss) before other expense                   (3,575,000) (3,030,000) (962,000)
Other expense                   (29,000) (35,000) (18,000)
Gain on sale of Algenist                   8,967,000 0 0
Income (loss) from discontinued operations before income taxes                   5,363,000 (3,065,000) (980,000)
Income tax provision                   2,062,000 0 0
Income (loss) from discontinued operations                   $ 3,301,000 $ (3,065,000) $ (980,000)